CRYO-CELL INTL COM USD0.01 (CCEL)

3.95
OTC Markets
Prev Close 3.92
Day Low/High 3.95 / 3.95
52 Wk Low/High 2.55 / 4.25
Exchange OTC Markets
Shares Outstanding 6.89B
Market Cap 27.03M
Div & Yield N.A. (N.A)

Cryo-Cell International Affiliate Earns Patent For Processing Umbilical Cord Blood For Therapeutic Use In Treating Neurodegenerative Diseases And Spinal Cord And Brain Injuries

The Valuable Cells Can be Used to Treat Parkinson's Disease, Huntington's Disease, Multiple Sclerosis, Alzheimer's Disease and Injuries to the Brain and Spinal Cord

Study Shows Promising Results Using Cord Blood Stem Cells To Treat Cerebral Palsy

Cryo-Cell International Chief Scientific Officer Optimistic That an Effective Treatment May be Found for Disability That Affects 10,000 Children Annually

Ki Yong Choi Reminds Cryo-Cell Stockholders To VOTE The GOLD Proxy Card For Director Nominees

Stockholders are reminded that their vote is important, no matter how many shares they own. It is not too late to vote, change your vote or get another GOLD proxy card to make a difference.

Leading Independent Proxy Advisory Firm Glass, Lewis & Co. Recommends Stockholders Vote To Elect All Of Mr. Choi's Director Nominees

GLASS LEWIS AFFIRMS THE NEED FOR CHANGE ON CRYO-CELL BOARD AND RECOMMENDS STOCKHOLDERS VOTE ON THE GOLD PROXY CARD

ISS Recommends Change At The Cryo-Cell Board Level

REPORT CITES CONCERNS WITH CRYO-CELL GOVERNANCE AND COMPENSATION PRACTICES

Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership And Board Of Directors In Proxy Contest

Saneron recommends that Cryo-Cell shareholders retain the current leadership and Board.

Ki Yong Choi Warns The Portnoys To Stop Deceiving Stockholders

CRYO-CELL'S LARGEST STOCKHOLDER REFUTES MANAGEMENT ACCUSATIONS